Condition
CMC Arthritis
Total Trials
3
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Not Yet Recruiting1
Unknown1
Recruiting1
Clinical Trials (3)
Showing 3 of 3 trials
NCT06820528Not ApplicableRecruitingPrimary
Trapeziectomy and Suture Suspensionplasty for Thumb Carpometacarpal Arthritis - Is In-Clinic Therapy Needed?
NCT06467669Not ApplicableNot Yet RecruitingPrimary
Predictive Outcomes for Selective Thumb Carpometacarpal Joint Denervation
NCT05835830UnknownPrimary
Thumb Metacarpophalangeal Hyperextension in an Arthritic Population; Part 2
Showing all 3 trials